Oncolytic Adenovirus Armoring with CXCL9 and IL15 Shows Potent Antitumor Activity and Boosts CAR-T Therapy for Prostate Cancer
Human Gene Therapy · 01.06.2025 · 36 (11-12) · 884-901
DOI: 10.1089/hum.2024.254 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Gene Therapy, erschienen am 01.06.2025. Verfasst von Lin Fang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Institute, Xuzhou Medical University, Xuzhou, China. Hauptthemen laut MEDLINE: Adenoviridae, Chemokine CXCL9, Prostatic Neoplasms, Oncolytic Viruses. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Institute, Xuzhou Medical University, Xuzhou, China.
- Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
- Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, China.
- Department of Oncology, Xuzhou City Hospital of TCM, Xuzhou, Jiangsu, China.
- Department of Oncology, The First People's Hospital of Yancheng, Yancheng, Jiangsu, China.
ORCID-Profile: Junnian Zheng
Zitieren
APA
Fang, L., Wang, X., Zhang, Y., Zhang, C., Liu, X., Li, W., Zhang, Y., Sun, N., Zheng, J., & Wang, G. (2025). Oncolytic Adenovirus Armoring with CXCL9 and IL15 Shows Potent Antitumor Activity and Boosts CAR-T Therapy for Prostate Cancer. Human Gene Therapy, 36(11-12), 884-901. https://doi.org/10.1089/hum.2024.254
Vancouver
Fang L, Wang X, Zhang Y, Zhang C, Liu X, Li W, et al. Oncolytic Adenovirus Armoring with CXCL9 and IL15 Shows Potent Antitumor Activity and Boosts CAR-T Therapy for Prostate Cancer. Human Gene Therapy. 2025;36(11-12):884-901. doi:10.1089/hum.2024.254
BibTeX
@article{Fang2025,
author = {Fang, Lin and Wang, Xueyan and Zhang, Yi and Zhang, Chen and Liu, Xiaoxiao and Li, Wanjing and Zhang, Yuxin and Sun, Nan and Zheng, Junnian and Wang, Gang},
title = {Oncolytic Adenovirus Armoring with CXCL9 and IL15 Shows Potent Antitumor Activity and Boosts CAR-T Therapy for Prostate Cancer},
journal = {Human Gene Therapy},
year = {2025},
volume = {36},
number = {11-12},
pages = {884--901},
doi = {10.1089/hum.2024.254}
}
EUVIMED